Who invested in PellePharm

6 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$78Mraised across 6 rounds since 2014, from 6 sources

$476KVenture$1.3MVenture$1.8MVenture$119KVenture$4.5MVenture$70MRound

Latest round: Round, $70MNov 2018
Step-upi: 15.4×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015201620172018

$476KVenture$1.3MVenture$1.8MVenture$119KVenture$70MRound

First round: Venture, $476K
Biggest round: $70M
Usual gap between rounds: 6 months

The rounds

Nov 2018
Round$70M1 new
- LEO Pharma
Reported by Xconomy
Jul 2015
Venture$4.5M
No investor was named in the report.
From a historical funding recordSEC filing: $4.5M sold, first sale Jul 2015
May 2015
Venture$119K
No investor was named in the report.
From a historical funding recordSEC filing: $119K sold, first sale Jan 2015
Apr 2015
Venture$1.8M
No investor was named in the report.
From a historical funding recordSEC filing: $1.8M sold, first sale Mar 2015
Oct 2014
Venture$1.3M
No investor was named in the report.
From a historical funding recordSEC filing: $1.3M sold, first sale Oct 2014
Jul 2014
Venture$476K
No investor was named in the report.
From a historical funding recordSEC filing: $476K sold, first sale Jun 2014

Founders and team

From the SEC filings it signed: 1 on the team.

Sanuj RavinddranExecutive Officer, Director, Promoteri

On the board, as filediErvin EpsteinFrank McCormickJean Y. TangNeil Kumar

Everyone who backed them

LEO PharmaCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list PellePharm as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.